These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9081560)

  • 41. Greater left cerebral hemispheric metabolism in bulimia assessed by positron emission tomography.
    Wu JC; Hagman J; Buchsbaum MS; Blinder B; Derrfler M; Tai WY; Hazlett E; Sicotte N
    Am J Psychiatry; 1990 Mar; 147(3):309-12. PubMed ID: 2309947
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease.
    Haxby JV; Duara R; Grady CL; Cutler NR; Rapoport SI
    J Cereb Blood Flow Metab; 1985 Jun; 5(2):193-200. PubMed ID: 3988821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [No hypofrontality in schizophrenia demonstrated by positron emission tomography].
    Biver F; Delvenne V; Goldman S; Luxen A; De Maertelaer V; Lotstra F; Mendlewicz J
    Acta Psychiatr Belg; 1992; 92(5):261-78. PubMed ID: 1345405
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors of cognitive change in middle-aged and older adults with memory loss.
    Small GW; La Rue A; Komo S; Kaplan A; Mandelkern MA
    Am J Psychiatry; 1995 Dec; 152(12):1757-64. PubMed ID: 8526242
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Visuoconstructive performance and regional cerebral glucose metabolism in Alzheimer's disease.
    Ober BA; Jagust WJ; Koss E; Delis DC; Friedland RP
    J Clin Exp Neuropsychol; 1991 Sep; 13(5):752-72. PubMed ID: 1955530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cortical responses to sustained and divided attention in Alzheimer's disease.
    Johannsen P; Jakobsen J; Bruhn P; Gjedde A
    Neuroimage; 1999 Sep; 10(3 Pt 1):269-81. PubMed ID: 10458942
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment].
    Cao Q; Jiang K; Liu Y; Zhang M; Xiao S; Zuo C; Huang H
    Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1613-6. PubMed ID: 12667368
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Positron emission tomography in normal aging and Alzheimer's disease.
    Rapoport SI
    Gerontology; 1986; 32 Suppl 1():6-13. PubMed ID: 3488245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlations between cognitive impairment, middle cerebral artery flow velocity and cortical glucose metabolism in the early phase of Alzheimer's disease.
    Franceschi M; Alberoni M; Bressi S; Canal N; Comi G; Fazio F; Grassi F; Perani D; Volonté MA
    Dementia; 1995; 6(1):32-8. PubMed ID: 7728217
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relation of EEG alpha background to parietal lobe function in Alzheimer's disease as measured by positron emission tomography and psychometry.
    Sheridan PH; Sato S; Foster N; Bruno G; Cox C; Fedio P; Chase TN
    Neurology; 1988 May; 38(5):747-50. PubMed ID: 3258970
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Compensatory recruitment of neural resources during overt rehearsal of word lists in Alzheimer's disease.
    Woodard JL; Grafton ST; Votaw JR; Green RC; Dobraski ME; Hoffman JM
    Neuropsychology; 1998 Oct; 12(4):491-504. PubMed ID: 9805319
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuropsychological functions in variant Alzheimer's disease with spastic paraparesis.
    Verkkoniemi A; Ylikoski R; Rinne JO; Somer M; Hietaharju A; Erkinjuntti T; Viitanen M; Kalimo H; Haltia M
    J Neurol Sci; 2004 Mar; 218(1-2):29-37. PubMed ID: 14759630
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Topographical analysis of glucose metabolism, as measured with positron emission tomography, in dementia of the Alzheimer type: use of linear histograms.
    McNamara D; Horwitz B; Grady CL; Rapoport SI
    Int J Neurosci; 1987 Sep; 36(1-2):89-97. PubMed ID: 3498701
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased brain glucose metabolism in microvessels from patients with Alzheimer's disease.
    Marcus DL; Freedman ML
    Ann N Y Acad Sci; 1997 Sep; 826():248-53. PubMed ID: 9329696
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brain glucose metabolism in Alzheimer's disease.
    Swerdlow R; Marcus DL; Landman J; Kooby D; Frey W; Freedman ML
    Am J Med Sci; 1994 Sep; 308(3):141-4. PubMed ID: 8074128
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alzheimer's disease with prominent visual symptoms. Clinical and metabolic evaluation.
    Kiyosawa M; Bosley TM; Chawluk J; Jamieson D; Schatz NJ; Savino PJ; Sergott RC; Reivich M; Alavi A
    Ophthalmology; 1989 Jul; 96(7):1077-85; discussion 1085-6. PubMed ID: 2788851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PET sheds light on Alzheimer's disease genetic risk.
    Swerdlow RH
    Proc Natl Acad Sci U S A; 2007 Nov; 104(48):18881-2. PubMed ID: 18025455
    [No Abstract]   [Full Text] [Related]  

  • 58. Relations among age, visual memory, and resting cerebral metabolism in 40 healthy men.
    Haxby JV; Grady CL; Duara R; Robertson-Tchabo EA; Koziarz B; Cutler NR; Rapoport SI
    Brain Cogn; 1986 Oct; 5(4):412-27. PubMed ID: 3495280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gender-related differences in regional cerebral glucose metabolism in normal volunteers.
    Andreason PJ; Zametkin AJ; Guo AC; Baldwin P; Cohen RM
    Psychiatry Res; 1994 Feb; 51(2):175-83. PubMed ID: 8022952
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A correlation between gene transcriptional activity and cerebral glucose metabolism in Alzheimer's disease-affected neocortex: cause or effect?
    Lukiw WJ; Handley P; Sutherland MK; Wong L; McLachlan DR
    Adv Exp Med Biol; 1991; 291():249-56. PubMed ID: 1927687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.